Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Vera Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 176 | 6 | 214 | +44 |
| Shares | 65.1M | 364.8K | 74.0M | +9.28M (+14.3%) |
| Value | $1.89B | $10.6M | $3.75B | +$1.87B (+99.3%) |
6 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (62)
Institutions that held Vera Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (18)
Institutions that held Vera Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Tang Capital Management LLC | 1,350,000 | $39.2M |
| MPM Oncology Impact Management LP | 563,075 | $16.4M |
| Capricorn Fund Managers Ltd | 450,700 | $13.1M |
| Hudson Bay Capital Management LP | 440,591 | $12.8M |
| HSBC Holdings PLC | 297,017 | $8.63M |
| HighVista Strategies LLC | 91,189 | $2.65M |
| SummitTX Capital, L.P. | 87,653 | $2.55M |
| Verition Fund Management LLC | 40,877 | $1.19M |
| HRT Financial LP | 40,851 | $1.19M |
| Atom Investors LP | 22,539 | $655.0K |
| Engineers Gate Manager LP | 22,138 | $643.3K |
| Aquatic Capital Management LLC | 20,786 | $604.0K |
| Jane Street Group, LLC | 13,042 | $379.0K |
| Capstone Investment Advisors, LLC | 11,983 | $348.2K |
| Walleye Trading LLC | 5,225 | $151.8K |
| Fifth Third Bancorp | 4,330 | $125.8K |
| Advisory Services Network, LLC | 10 | $291 |
| IFP Advisors, Inc | 6 | $174 |
Not filed for Q4 2025 yet (6)
Institutions that held Vera Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| AXA Investment Managers S.A. | 229,640 | $6.67M |
| Cubist Systematic Strategies, LLC | 96,871 | $2.82M |
| Yale University | 22,810 | $662.9K |
| Corton Capital Inc. | 10,562 | $306.9K |
| Point72 (DIFC) Ltd | 3,735 | $108.5K |
| Point72 Europe (London) LLP | 1,230 | $35.7K |